These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23342871)

  • 21. Crohn's disease in a patient with juvenile idiopathic arthritis after starting etanercept therapy - causal link or only temporal coincidence?
    Flemming GM; Tóth G; Gebauer C; Schuster V
    Klin Padiatr; 2013 Nov; 225(6):350-1. PubMed ID: 24166091
    [No Abstract]   [Full Text] [Related]  

  • 22. Breast cancer in a male with ankylosing spondylitis treated with TNFalpha antagonists.
    El Mansouri L; Couchouron T; Le Roux G; Dugast C; Burtin F; Albert JD; Perdriger A; Hassouni NH; Chalès G
    Joint Bone Spine; 2009 Jul; 76(4):421-3. PubMed ID: 19457692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The role of biologic agents in the therapy of ankylosing spondylitis].
    Géher P; Nagy MB; Péntek M; Tóth E; Brodszky V; Gulácsi L
    Orv Hetil; 2006 Jul; 147(26):1203-13. PubMed ID: 16898082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etanercept-induced Crohn's disease in ankylosing spondylitis: a case report and review of the literature.
    Tolu S; Rezvani A; Hindioglu N; Calkin Korkmaz M
    Rheumatol Int; 2018 Nov; 38(11):2157-2162. PubMed ID: 30293157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Focus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients.
    Gerloni V; Pontikaki I; Gattinara M; Fantini F
    Ann Rheum Dis; 2008 Aug; 67(8):1145-52. PubMed ID: 17981916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series.
    Cohen JD; Bournerias I; Buffard V; Paufler A; Chevalier X; Bagot M; Claudepierre P
    J Rheumatol; 2007 Feb; 34(2):380-5. PubMed ID: 17013997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Onset of lichen planus during treatment with etanercept.
    Musumeci ML; Lacarrubba F; Micali G
    Am J Clin Dermatol; 2010; 11 Suppl 1():55-6. PubMed ID: 20586513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment patterns in the first year after initiating tumor necrosis factor blockers in real-world settings.
    Bonafede M; Fox KM; Watson C; Princic N; Gandra SR
    Adv Ther; 2012 Aug; 29(8):664-74. PubMed ID: 22886712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Switching from infliximab to once-weekly administration of 50 mg etanercept in resistant or intolerant patients with ankylosing spondylitis: results of a fifty-four-week study.
    Cantini F; Niccoli L; Benucci M; Chindamo D; Nannini C; Olivieri I; Padula A; Salvarani C
    Arthritis Rheum; 2006 Oct; 55(5):812-6. PubMed ID: 17013842
    [No Abstract]   [Full Text] [Related]  

  • 30. [Anti-TNF alfa therapy in ankylosing spondylitis].
    Cravo AR; Tavares V; Da Silva JC
    Acta Med Port; 2006; 19(2):141-50. PubMed ID: 17187716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Membranous glomerulonephritis with the use of etanercept in ankylosing spondylitis.
    Kaushik P; Rahmani M; Ellison W
    Ann Pharmacother; 2011 Dec; 45(12):e62. PubMed ID: 22116994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment of alopecia universalis with alefacept: a case report and review of the literature.
    Bui K; Polisetty S; Gilchrist H; Jackson SM; Frederic J
    Cutis; 2008 May; 81(5):431-4. PubMed ID: 18543595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis.
    Brandt J; Listing J; Haibel H; Sörensen H; Schwebig A; Rudwaleit M; Sieper J; Braun J
    Rheumatology (Oxford); 2005 Mar; 44(3):342-8. PubMed ID: 15561737
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Side effects of anti-TNFalpha therapy in juvenile idiopathic arthritis].
    Pontikaki I; Gerloni V; Gattinara M; Luriati A; Salmaso A; De Marco G; Teruzzi B; Valcamonica E; Fantini F
    Reumatismo; 2006; 58(1):31-8. PubMed ID: 16639486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infliximab, but not etanercept, induces IgM anti-double-stranded DNA autoantibodies as main antinuclear reactivity: biologic and clinical implications in autoimmune arthritis.
    De Rycke L; Baeten D; Kruithof E; Van den Bosch F; Veys EM; De Keyser F
    Arthritis Rheum; 2005 Jul; 52(7):2192-201. PubMed ID: 15986349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment with infliximab in a patient with ankylosing spondylitis and Crohn's disease.
    Rednic S; Marinescu C; Chira R; Rogojan L; Rednic N
    J Gastrointestin Liver Dis; 2006 Dec; 15(4):379-82. PubMed ID: 17205151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha.
    Gorman JD; Sack KE; Davis JC
    N Engl J Med; 2002 May; 346(18):1349-56. PubMed ID: 11986408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alopecia areata during etanercept therapy.
    Pan Y; Rao NA
    Ocul Immunol Inflamm; 2009; 17(2):127-9. PubMed ID: 19412875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-TNF-alpha treatment: a possible promoter in endogenous uveitis? observational report on six patients: occurrence of uveitis following etanercept treatment.
    Kakkassery V; Mergler S; Pleyer U
    Curr Eye Res; 2010 Aug; 35(8):751-6. PubMed ID: 20673052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of infliximab and etanercept, two types of anti-tumor necrosis factor-alpha inhibitor on serum level of matrix metalloproteinase 3 expression in patients with ankylosing spondylitis].
    Yang CH; Huang F; Deng XH; Zhang JL; Zhang LY; Guo JH; Liang DF; Wang LS; Zhang YM
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2451-4. PubMed ID: 17156669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.